Le Lézard
Classified in: Health, Business
Subjects: CCA, BFA, FVT

Torchmark Corporation Announces Second Quarter 2018 Earnings Release And Conference Call


MCKINNEY, Texas, July 13, 2018 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Second Quarter 2018 earnings after the market closes on Wednesday, July 25, 2018.  At that time a copy of the Company's Q2-2018 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at www.torchmarkcorp.com on the Investors page.  In conjunction with Torchmark's Second Quarter 2018 Earnings Release, you are invited to listen to a conference call that will be broadcast live over the Internet on Thursday, July 26, 2018 at 11:00 am Eastern (10:00 am Central).

Second Quarter Conference Call
Thursday, July 26, 2018
11:00 a.m. (Eastern)

Listen live and as a replay at www.torchmarkcorp.com 
on the Investors /Calls and Meetings page
under "Conference Calls on the Web" and as a replay under "Conference Call Replays and Transcripts"
or

Call-In Number: 

334-323-0522

(Pass Code:  Torchmark)

Torchmark Corporation is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies.  Torchmark has several nationally recognized insurance subsidiaries.  Globe Life And Accident is a direct-response provider of life insurance known for its administrative efficiencies.  American Income Life provides individual life insurance to working families.  Liberty National Life is one of the oldest traditional life insurers in the Southeast.  United American is a consumer-oriented provider of supplemental life and health insurance.  Family Heritage Life provides individual supplemental health insurance.

 

SOURCE Torchmark Corporation


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: